Pricing

Apogee Therapeutics

1 follower

‌

Apogee Therapeutics, Inc. is a biotechnology company advancing novel therapies to address patients’ needs. Based in San Francisco and backed by leading life sciences funds, the company expects its lead pipeline program to enter clinical trials in 2023.

Industries

Headquarters

San Francisco, United States

Employees

Links

Org chart

Michael Henderson

Chief Executive Officer at Apogee Therapeutics

Michael Henderson

Collapse

Carl Dambkowski

Chief Medical Officer

Senior Vice President, Business Development and Strategy

Senior Vice-President, Regulatory Affairs & Toxicology

Vp, Head Of People

Jane Pritchett Henderson

Chief Financial Officer

Wendy Aspden-Curran

Senior Vice President, Clinical Operations

Director, Regulatory Affairs

Mehrak Kiankarimi

Senior Vice President, Operations and Program Management

Kristine Nograles

SVP, Clinical Development

Co-Founder and Board Director

Senior Vice President, Quality Assurance

Senior Vice President, IT

Lukas Dillinger

Vice President, Research and Translational Medicine

Rebecca Dabora, PhD

Chief Technical Officer

Chief Commercial Officer

Teams

Leadership Team

15 members

Clinical Operations and Development

5 members

People and Talent Team

4 members

Business and Strategy

3 members

Regulatory Affairs and Quality Assurance Team

3 members

Similar companies

Tessera Therapeutics

2 followers

Vaxcyte

2 followers

Halda Therapeutics

1 follower

Artiva Biotherapeutics

1 follower

Thermo Fisher Scientific

158 followers

CRISPR Therapeutics

9 followers

Adverum Biotech

8 followers

Legend Biotech

5 followers

Artivion

3 followers

Verve Therapeutics

54 followers

ImmunityBio

2 followers

Explore companies